Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Expert Review of Hematology|November 19, 2010
Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantationBeatriz Martín-Antonio, Miquel Granell, Alvaro Urbano-IspizuaGastroenterologia Y Hepatologia|November 6, 2007
[Imatinib-induced toxic hepatitis: description of two cases and review of the literature]Francisco Fuster, Luis Medina, Rolando Vallansot, et al.Archivos De Bronconeumologia|September 18, 2012
Recurrent endobronchial diffuse large B-cell lymphoma. Diagnosed by cryoprobeVirginia Pajares, Alfons Torrego, Miquel Granell, et al.Cancer Letters|February 14, 2006
Sonic hedgehog mRNA expression by real-time quantitative PCR in normal and tumor tissues from colorectal cancer patientsMariano Monzo, Isabel Moreno, Rosa Artells, et al.British Journal of Haematology|June 3, 2006
Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasiaFrancisco Cervantes, Alberto Alvarez-Larrán, Juan-Carlos Hernández-Boluda, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Anemia associated with impaired erythropoietin secretion after allogeneic stem cell transplantation: incidence, risk factors, and response to treatmentAnna Gaya, Alvaro Urbano-Ispizua, Francesc Fernández-Avilés, et al.Annals of Hematology|December 18, 2019
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)Albert Esquirol, Sergi Querol, Irene Garcia-Cadenas, et al.Leukemia & Lymphoma|September 16, 2020
Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myelomaAlbert Oriol, Gladys Ibarra, Eugènia Abella, et al.Leukemia Research|December 28, 2010
Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemiaMargherita Maffioli, Mireia Camós, Anna Gaya, et al.British Journal of Haematology|May 15, 2015
A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosisMaria T Cibeira, Albert Oriol, Juan J Lahuerta, et al.Pageof 4